Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mu-Hsin Chang

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Head & Neck|April 4, 2017
Effectiveness of incorporating cetuximab into docetaxel/cisplatin/fluorouracil induction chemotherapy and chemoradiotherapy for inoperable squamous cell carcinoma of the oral cavity: A phase II studyPeter Mu-Hsin Chang, Hsueh-Ju Lu, Ling-Wei Wang, et al.
Journal of the Chinese Medical Association : JCMA|January 8, 2026
Multi-agent chemotherapy for refractory head and neck cancerI-Wei Ho, Tien-Hua Chen, Peter Mu-Hsin Chang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 13, 2009
Prolonged facial edema is an indicator of poor prognosis in patients with head and neck squamous cell carcinomaMing-Huang Chen, Peter Mu-Hsin Chang, Po-Min Chen, et al.
The Oncologist|March 10, 2025
Efficacy of atezolizumab combined with platinum and etoposide in the treatment of extrapulmonary neuroendocrine carcinomaI-Wei Ho, Nai-Jung Chiang, Jiun-I Lai, et al.
Japanese Journal of Clinical Oncology|February 8, 2011
A study using ifosfamide and etoposide in patients with cisplatin-refractory recurrent or metastatic head and neck squamous cell carcinomaYu-Chung Huang, Peter Mu-Hsin Chang, Ming-Huang Chen, et al.
Journal of Cancer Research and Clinical Oncology|June 25, 2009
Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancerMing-Huang Chen, Peter Mu-Hsin Chang, Po-Min Chen, et al.
Japanese Journal of Clinical Oncology|October 4, 2011
Sunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinomaYao-Chung Liu, Peter Mu-Hsin Chang, Chun-Yu Liu, et al.
Free Radical Biology & Medicine|July 14, 2026
Nicotine drives lung cancer progression by suppressing cuproptosis through the LIAS-DLAT axis and promoting M2 macrophage polarizationYi-Fang Yang, Min-Hsi Lin, Yu-Yu Lin, et al.
Journal of Dental Sciences|January 26, 2026
Adjuvant metronomic tegafur-uracil is associated with poorer outcomes and unfavorable histopathologic progression in oral squamous cell carcinomasKai-Feng Hung, Yi-Ping Wang, Yi-Chen Sun, et al.
Royal Society Open Science|April 10, 2020
Oncogene inference optimization using constraint-based modelling incorporated with protein expression in normal and tumour tissuesWu-Hsiung Wu, Fan-Yu Li, Yi-Chen Shu, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Head & Neck|April 4, 2017
Effectiveness of incorporating cetuximab into docetaxel/cisplatin/fluorouracil induction chemotherapy and chemoradiotherapy for inoperable squamous cell carcinoma of the oral cavity: A phase II studyPeter Mu-Hsin Chang, Hsueh-Ju Lu, Ling-Wei Wang, et al.
Journal of the Chinese Medical Association : JCMA|January 8, 2026
Multi-agent chemotherapy for refractory head and neck cancerI-Wei Ho, Tien-Hua Chen, Peter Mu-Hsin Chang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 13, 2009
Prolonged facial edema is an indicator of poor prognosis in patients with head and neck squamous cell carcinomaMing-Huang Chen, Peter Mu-Hsin Chang, Po-Min Chen, et al.
The Oncologist|March 10, 2025
Efficacy of atezolizumab combined with platinum and etoposide in the treatment of extrapulmonary neuroendocrine carcinomaI-Wei Ho, Nai-Jung Chiang, Jiun-I Lai, et al.
Japanese Journal of Clinical Oncology|February 8, 2011
A study using ifosfamide and etoposide in patients with cisplatin-refractory recurrent or metastatic head and neck squamous cell carcinomaYu-Chung Huang, Peter Mu-Hsin Chang, Ming-Huang Chen, et al.
Journal of Cancer Research and Clinical Oncology|June 25, 2009
Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancerMing-Huang Chen, Peter Mu-Hsin Chang, Po-Min Chen, et al.
Japanese Journal of Clinical Oncology|October 4, 2011
Sunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinomaYao-Chung Liu, Peter Mu-Hsin Chang, Chun-Yu Liu, et al.
Free Radical Biology & Medicine|July 14, 2026
Nicotine drives lung cancer progression by suppressing cuproptosis through the LIAS-DLAT axis and promoting M2 macrophage polarizationYi-Fang Yang, Min-Hsi Lin, Yu-Yu Lin, et al.
Journal of Dental Sciences|January 26, 2026
Adjuvant metronomic tegafur-uracil is associated with poorer outcomes and unfavorable histopathologic progression in oral squamous cell carcinomasKai-Feng Hung, Yi-Ping Wang, Yi-Chen Sun, et al.
Royal Society Open Science|April 10, 2020
Oncogene inference optimization using constraint-based modelling incorporated with protein expression in normal and tumour tissuesWu-Hsiung Wu, Fan-Yu Li, Yi-Chen Shu, et al.
Pageof 10